Top Industry Leaders in the Chiari Malformation Market
Latestย Chiari Malformationย Companiesย Updates:
Surgeonet's NeuroGlideยฎ Cervical Decompression System Received FDA approval in October 2023 for minimally invasive decompression surgery in patients with Chiari Type I Malformation. This offers an alternative to traditional, more invasive open surgery.
MDI's VentriFlowโข CSF Diversion System Phase 2 trial results presented in November 2023 showed promising effectiveness in managing syringomyelia associated with Chiari Malformation.
Novel Biomarkers Companies are exploring potential biomarkers for early detection and diagnosis of Chiari Malformation, aiming to improve patient outcomes and reduce unnecessary surgeries.
List ofย Chiari Malformationย Key companies in the market:
- Abbott Laboratories, Inc.
- Becton, Dickinson and Company
- Novartis AG
- Johnson & Johnson
- Pfizer, Inc.
- Sanofi-Aventis
- GlaxoSmithKlineย